Internal Server Error

Espero - About the company

Espero is an unfunded company based in Stonington (United States), founded in 2021 by Kimberly Tableman. It operates as a Provider of a software to digitize and streamline the clinical trial protocol. Espero has not raised any funding yet. The company has 304 active competitors, including 55 funded and 42 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.

Company Details

Provider of a software to digitize and streamline the clinical trial protocol. It streamline and digitize Clinical Trials through revolutionizing the protocol development process, with eProtocol. It automate study building, site selection, and connected workflows.
Key Metrics
Founded Year
2021
Location
Stonington, United States
Stage
Unfunded
Ranked
Employee Count
4 as on Apr 30, 2026
Similar Companies
Sign up to download Espero's company profile

Espero's funding and investors

Espero has not raised any funding rounds yet.

Espero's founders and board of directors

Founder? Claim Profile
The founders of Espero is Kimberly Tableman. Kimberly Tableman is the CEO of Espero.
Here are the details of Espero's key team members:

Espero's employee count trend

Espero has 4 employees as of Apr 26. Here is Espero's employee count trend over the years:
Employee count trend for Espero
lockUncover Espero's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Espero's Competitors and alternates

Top competitors of Espero include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Espero, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Medidata
Medidata
1999, New York City (United States), Acquired
AI-based clinical trial management software for researchers
$41.5M
86/100
2nd
Logo for Verily
Verily
2015, Dallas (United States), Series D
A data platform and technology company purpose-built to power AI-enabled precision health
$2.8B
82/100
3rd
Logo for IQVIA
IQVIA
1982, Durham (United States), Public
Provider of clinical research and commercialization solutions for healthcare
$1.74M
80/100
4th
Logo for Tempus
Tempus
2015, Chicago (United States), Public
Developer of genomic testing and artificial intelligence tools for medicine
$1.05B
78/100
5th
Logo for Signant Health
Signant Health
2000, Plymouth Meeting (United States), Acquired
Provider of a software solution for clinical trial management
$3.4M
72/100
6th
Logo for Science 37
Science 37
2014, Los Angeles (United States), Acquired
Provider of a suite solution for clinical trials for researchers
$106M
70/100
7th
Logo for Viz.ai
Viz.ai
2016, San Francisco (United States), Series D
Developer of an AI-powered platform for care coordination and disease detection
$252M
70/100
8th
Logo for Massive Bio
Massive Bio
2014, New York City (United States), Series B
Provider of AI-based clinical trial management tool
$15.6M
66/100
9th
Logo for TriNetX
TriNetX
2013, Cambridge (United States), Acquired
Provider of clinical trial management software for researchers and professionals
$102M
66/100
10th
Logo for BrightInsight
BrightInsight
2017, San Jose (United States), Series C
Provider of digital health solutions for clinical trials
$179M
64/100
256th
Logo for Espero
Espero
2021, Stonington (United States), Unfunded
Provider of a software to digitize and streamline the clinical trial protocol
-
-
18/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Espero's competitors? Click here to see the top ones

Espero's Investments and acquisitions

Espero has made no investments or acquisitions yet.

Reports related to Espero

Here is the latest report on Espero's geography:

FAQs about Espero

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford